Nanotech worries scientists
This article was originally published in The Rose Sheet
Executive Summary
The potential environmental and health effects of nanotechnology worry scientists more than they do the general public, a survey published Nov. 25 in the journal Nature Nanotechnology finds. Lead author Dietram Scheufele, a professor of life sciences communication and journalism as the University of Wisconsin-Madison, and Elizabeth Corley at Arizona State University conducted a national telephone survey of American householders and a sampling of leading nanotech scientists and engineers. Of the 363 scientists polled by Scheufele and Corley, 20% (versus 15% of the public) believed that new forms of nanotechnology pollution may emerge, and 30% (versus 20% of the public) expressed concern that the technology may endanger human health. "Nanotechnology is starting to emerge on the policy agenda, but with the public, it's not on their radar," Scheufele observes...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.